首页 > 

sports font

2025-01-25
SANTA CLARA — Brock Purdy is charged with distributing the ball to the 49ers’ still-plentiful array of offensive weapons. On Tuesday, he threw disgruntled wide receiver Deebo Samuel his full support. “I want to get Deebo the ball every play if I could,” Purdy said. “I want to have him break all the records as best as possible. I want Deebo to do Deebo things, and we all do in this building.” Thing is, Samuel’s sub-par production this season has mirrored the 49ers’ rocky road to a 6-7 record entering Thursday night’s visit by the Rams (7-6). “Not struggling at all just not getting the ball!!!!!!!” Samuel wrote Monday in a since-deleted post on the social media platform X. The timing off that complaint was peculiar. The 49ers had just shaken a three-game losing streak with a 38-13 win over the Chicago Bears, a game Samuel acknowledged was their best offensive showing and most complementary outing. But the 49ers did so with minimal production again from Samuel, who had two catches for 22 yards and five carries for 13 yards. “You read what you read. A little frustrated, for sure,” Samuel said Tuesday at his locker before practice. General manager John Lynch asked 49ers fans to give Samuel “some grace,” and coach Kyle Shanahan also threw support behind Samuel’s gripes. “Deebo and I talk every day so I understand Deebo saying that,” Shanahan said. “Deebo wants to help us out, and the only way he is helping us is getting the ball more. And we’d like to get him the ball more.” Samuel, a two-time captain, has scored just two touchdowns (Week 1 run, Week 5 reception) after 12 last regular season; he had 14 in 2021. He missed the 49ers’ Week 3 loss in Los Angeles because of a calf injury. Three years removed from his All-Pro breakout season, Samuel’s production has taken a nosedive this season, even though he is getting the ball. His 72 touches (40 receptions for 533 yards, 32 carries for 92 yards) are second to only now-injured running back Jordan Mason’s 164. In an X post 10 minutes after complaining about his opportunities, Samuel wrote : “Just cause I voice my opinions don’t mean I’m hating on any of my teammates!!” Jauan Jennings (57 catches, 774 yards, six touchdowns) and tight end George Kittle (56-800-8) have seized more on their targets from Brock Purdy, while 2022-23 mainstays Brandon Aiyuk and Christian McCaffrey have missed most of the season injured. “We’d always love things to stay in-house,” Shanahan said. “It’s probably why I don’t go on social media: I’d get worked up if I was reading stuff all the time. Is it a distraction in our building? No.” “He’s one of my best friends on this team. I absolutely love Deebo and what he’s done for me,” Purdy said. “He’s right: he’s doing great right now with what we ask of him the offense. He’s not struggling. Like Ricky (Pearsall) or Aiyuk last year a little bit, there are moments through a season where guys just don’t get the ball, depending on defensive schemes and taking guys away.” Samuel has flourished in the 49ers’ rivalry against the Rams, including three years ago when his “wide back” persona emerged as he scored on both a run and a reception to lead the victorious 49ers out of a 3-5 rut and toward the playoffs. That dual-threat duty is not such an inventive concept anymore, however. “They’re not surprised anymore,” Samuel said. “We’ve been doing it almost three years now, so you’ve got a 50-50 chance whether I’m in the backfield getting a handoff or anything along those lines. They have a glimpse of what’s going on. ... There’s three or four (defenders awaiting) no matter who has the ball.” “Deebo has created such a high standard, the things he’s done, the innovation which we’ve created things for Deebo. That’s part of the problem,” said Lynch, noting that multiple teams now deploy Samuel-esque, dual-threat players that no longer surprise defenses. “... That frustration mounts. But he’s made so many plays for us, I think we need to give this guy some grace and bring him along, because we need him the rest of the way,” Lynch added. “We need him Thursday night. Deebo’s a big part of this team. We’re alright. We can all learn from different situations and a lot of things in the world these days that you can get caught up in.” Some of Samuel’s most productive efforts this season have come as a kick returner (11 returns for 333 yards, including six returns in their Dec. 1 loss at Buffalo). “We’ve got a lot of big football to play and he’ll be a big part of our season moving forward,” Lynch said. As for next season, Samuel carries a $16 million mark on the salary cap. The 49ers restructured his contract in March, so he would incur a $31.6 million hit if he’s released or traded before June 1; after that date, an exit would count $11 million in 2025 and $21 million in ’26. GUERENDO IDLING Running back Isaac Guerendo’s foot sprain Sunday kept him out of Tuesday’s light walkthrough and it’s uncertain whether he’ll make a second straight start. Guerendo ran for 78 yards and two touchdowns, and he had 50 yards on two catches, before exiting and bequeathing the backfield to Patrick Taylor Jr. Guerendo got clocked at 20.2 mph on a 30-yard, second-quarter carry that was the NFL’s fastest by a running back in Week 14. GREENLAW UPDATE The 49ers remain reluctant to declare whether linebacker Dre Greenlaw will make his season debut Thursday night, the date pegged for his comeback from an Achilles tear in the Super Bowl. Shanahan said there’s been no setback, that he merely wants to talk first to Greenlaw and see how the next two days go. OTHER INJURY UPDATES Defensive end Nick Bosa (oblique, hip) and left tackle Trent Williams (ankle) will officially miss the fourth week of practice, albeit this week’s only consisting of Tuesday’s walk-through that began at 5:10 p.m. Shanahan has not indicated whether they’ll miss a fourth straight game. While left guard Aaron Banks practiced for the first time since a Nov. 24 concussion in Green Bay, guard Ben Bartch (ankle) did not practice and is expected to go on Injured Reserve before Thursday’s kickoff. Limited were defensive end Yetur Gross-Matos, safety Malik Mustapha, and linebackers Dee Winters and Demetrius Flannigan-Fowles. HARGRAVE MOVEMENT Defensive tackle Javon Hargrave’s bloated contract was restructured to lessen the 49ers’ financial restraints next year. While that could stage his potential release after two seasons, as pointed out by OverTheCap.com, Hargrave is also more affordable to keep, seeing how his 2025 salary was chopped from $19.9 million to $2.1 million, and his salary cap mark fell from $28 million to $10.3 million. “The plan for him is to be a Niner,” Shanahan said, deferring business matters to the front office staff. “The mechanics of contract stuff, those are things I don’t look into until after the offseason.” Hargrave, 31, has been on injured reserve since tearing a biceps in the Sept. 22 loss at Los Angeles. He made the Pro Bowl last season and totaled seven sacks in his first year with the 49ers. Jordan Elliott replaced him in this season’s lineup next to Maliek Collins, with rookie Evan Anderson, Kevin Givens, Kalia Davis and Khalil Davis also in the interior rotation.The 8th Asian Forging Conference was successfully held in Wuhan, Chinasports font

Mayor and LAPD chief tout double-digit drop in homicides compared to last yearLiverpool remain perfect in Europe as Madrid misery continues

Movie review: ‘Mufasa: The Lion King’ a boundary-pushing prequel worthy of original filmWith two of Niagara-on-the-Lake’s pharmacies back under local ownership, its former owner — now a partial owner — hopes it can get back to providing exceptional customer service. Both Simpson’s Pharmasave in Virgil and Pharmasave Simpson’s Apothecary in Old Town were sold on Oct. 18, with partial ownership returning to Sean Simpson. After initially selling the stores to SRx Health Solutions, a Toronto-based pharmaceutical company, in 2023 for an undisclosed amount, Simpson approached the Boggio Family of Pharmacies, a Niagara-based pharmaceutical business, to buy the stores back together. Aaron and Kyle Boggio were happy to join in on the venture. The Boggios are now two of six major shareholders of the company, including Sean and Stephanie Simpson and Connor and Morgan Gates, both with the Boggio Family of Pharmacies. Before talking to the Boggios, Simpson approached SRx about buying the stores back. With their permission, he then approached the Boggios, he said. Simpson would not share the percentage of his stake in the company, nor that of the other shareholders. He also did not disclose how much he and the Boggios paid to buy back the pharmacies. The Boggio Family of Pharmacies, in operation since 1983, has several locations across the Niagara region — now including the two in NOTL. “I’ve known the Simpsons for many years. I actually did an internship with them back when I was coming out of pharmacy school,” said Aaron Boggio. “I know their values align with our values at Boggio Family Pharmacies and they are strong supporters of the community.” Despite giving up ownership of Simpson’s Pharmasave, Simpson never really left the company, assuming the title of pharmacy liaison after the sale. However, he wanted to increase his share in the company after noticing a decline in the quality of customer service at the pharmacies and supply issues after the new owners took over, he said. “It got to a point where it became very apparent to me that the business was going to suffer if something wasn’t done,” Simpson said. From there, Simpson asked permission to buy back the company and reached out to the Boggios to go into business together. “I’m very confident now with the group, especially our local roots and local presence, that I think is going to help us get back to the service standard that we are known for and what people expect from us,” he said. Boggio said the former owners didn’t necessarily have the level of care small-community customers expect. “That’s something that we look forward to bringing back to Niagara-on-the-Lake,” he said. “We are a local owner and we treat our customers like family.” With the swap, Boggio said customers shouldn’t expect too much of a change aside from increased levels of customer service. “Because we have so many stores locally there’s an opportunity for us to better service our patients, our pharmacies work as a family so we can share stock and do whatever it takes to get the product to the patient who needs it,” he said. Simpson said there is no limit to the level of customer service those visiting the pharmacy can expect. “I’m really looking forward to the next few years and really trying to not only get back to where we were but to exceed that level and raise the standard even higher,” he said. juliasacco@niagaranow.comIf it ain't broke: Many large companies and organizations are often ridiculed for using outdated computers, but not every business requires the latest digital technology. Case in point: a bakery in Indiana has been photographed processing sales using a Commodore 64. This isn't the first time a 21st-century business has been spotted using the top-selling 1982 PC, as the device remains beloved by enthusiasts today. Photos have recently surfaced showing that Hilligoss Bakery in Brownsburg, Indiana, uses a pair of Commodore 64s as cash registers. While running a business on a 42-year-old PC might seem unusual, the device likely has sufficient processing power to ring up orders of donuts. The pictures, originally taken in 2010, recently reappeared on social media. The C64s were also visible in another photo from 2021. Hilligoss Bakery appears to have a strong reputation, boasting a 4.7 rating on Google Maps and a 4.4 on Yelp. Apparently, a Doughnut shop in U.S. is still using a Commodore 64 for business. pic.twitter.com/i7gO90JAZ4 The Commodore 64, released in 1982, apparently remains the best-selling individual PC model of all time, with estimated sales between 10 and 17 million units. Priced at $595 upon release (approximately $1,945 in 2024 dollars), the system featured a 1 MHz CPU and 64KB of RAM, hence its name. While most of the C64's 10,000 software titles were games, it also supported business software, which companies like Hilligoss Bakery continue to use. It's unclear whether the bakery has been using the Commodore 64s since 1982, but it's possible, given that the business has been operating since 1974 and is celebrating its 50th anniversary this year. Must read: The Commodore Story: Gone But Not Forgotten This isn't the only instance of businesses clinging to the Commodore 64. The Commodore USA Facebook page highlighted another example in 2016: an auto repair shop in Poland that has used a Commodore 64 to balance driveshafts since at least 1991 – even surviving a flood at one point. In certain cases, using older technology can reduce costs and offer security through obscurity. For instance, Southwest Airlines avoided the infamous CrowdStrike data breach by continuing to use Windows 95. However, maintaining and repairing vintage equipment can pose significant challenges. Fortunately, the enduring popularity of the Commodore 64 ensures that replacements, restorations, and repairs are still possible. Last year, a dedicated modder demonstrated that it's feasible to build a new Commodore 64 from scratch using replacement parts. Additionally, a modern recreation of the device, released in 2019, supports original software and connects to modern displays via HDMI.

GC Aesthetics® anuncia una década de evaluación clínica de los implantes mamarios PERLETMVictory Capital Management Inc. increased its position in shares of Viper Energy, Inc. ( NASDAQ:VNOM – Free Report ) by 233.0% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 95,892 shares of the oil and gas producer’s stock after buying an additional 67,098 shares during the period. Victory Capital Management Inc.’s holdings in Viper Energy were worth $4,326,000 as of its most recent filing with the SEC. Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. New York State Teachers Retirement System purchased a new stake in shares of Viper Energy during the 3rd quarter worth about $984,000. Sei Investments Co. raised its holdings in Viper Energy by 81.9% in the 1st quarter. Sei Investments Co. now owns 45,308 shares of the oil and gas producer’s stock worth $1,743,000 after purchasing an additional 20,396 shares during the period. Amalgamated Bank purchased a new position in Viper Energy during the second quarter worth approximately $616,000. Vanguard Group Inc. grew its holdings in Viper Energy by 23.3% in the first quarter. Vanguard Group Inc. now owns 8,481,119 shares of the oil and gas producer’s stock valued at $326,184,000 after purchasing an additional 1,603,333 shares during the period. Finally, Assenagon Asset Management S.A. increased its position in shares of Viper Energy by 326.0% in the second quarter. Assenagon Asset Management S.A. now owns 760,830 shares of the oil and gas producer’s stock valued at $28,554,000 after buying an additional 582,247 shares in the last quarter. Institutional investors and hedge funds own 87.72% of the company’s stock. Viper Energy Stock Up 3.4 % VNOM stock opened at $56.55 on Friday. The company has a current ratio of 7.24, a quick ratio of 7.24 and a debt-to-equity ratio of 0.25. The firm has a 50-day moving average of $50.24 and a two-hundred day moving average of $44.20. Viper Energy, Inc. has a 12 month low of $29.03 and a 12 month high of $56.63. The company has a market cap of $10.65 billion, a price-to-earnings ratio of 23.86 and a beta of 1.72. Viper Energy Announces Dividend The business also recently declared a quarterly dividend, which was paid on Thursday, November 21st. Stockholders of record on Thursday, November 14th were issued a dividend of $0.30 per share. The ex-dividend date of this dividend was Thursday, November 14th. This represents a $1.20 annualized dividend and a dividend yield of 2.12%. Viper Energy’s dividend payout ratio is presently 51.50%. Wall Street Analysts Forecast Growth A number of brokerages have recently issued reports on VNOM. Barclays increased their target price on Viper Energy from $52.00 to $58.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. TD Securities increased their price objective on shares of Viper Energy from $46.00 to $48.00 and gave the company a “buy” rating in a report on Thursday, September 12th. Truist Financial lifted their target price on shares of Viper Energy from $57.00 to $64.00 and gave the company a “buy” rating in a research report on Wednesday, November 6th. Raymond James upped their price target on shares of Viper Energy from $58.00 to $62.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, StockNews.com cut Viper Energy from a “hold” rating to a “sell” rating in a report on Tuesday, November 5th. One analyst has rated the stock with a sell rating and eight have issued a buy rating to the company. According to MarketBeat, Viper Energy presently has a consensus rating of “Moderate Buy” and a consensus target price of $54.75. Read Our Latest Stock Analysis on Viper Energy Viper Energy Profile ( Free Report ) Viper Energy, Inc owns and acquires mineral and royalty interests in oil and natural gas properties in the Permian Basin, North America. Viper Energy Partners GP LLC operates as the general partner of the company. The company was formerly known as Viper Energy Partners LP and changed its name to Viper Energy, Inc in November 2023. Recommended Stories Want to see what other hedge funds are holding VNOM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Viper Energy, Inc. ( NASDAQ:VNOM – Free Report ). Receive News & Ratings for Viper Energy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viper Energy and related companies with MarketBeat.com's FREE daily email newsletter .

This article is Sponsored Content by Kim Seokjin Lab For centuries, humanity’s primary health focus has been a reactive approach — fighting diseases and simply extending life expectancy. The World Health Organization’s recent data tells a transformative story: global life expectancy is steadily increasing, with some regions approaching the remarkable milestone of 100 years. However, this extended lifespan represents more than just additional years — it’s an opportunity to redefine what it means to be truly healthy. The modern health paradigm is shifting from mere survival to comprehensive vitality. Today’s consumers are not satisfied with just avoiding illness; they seek to optimize their health, maintain high energy levels, and ensure quality of life at every stage of their journey. This philosophical change has profound implications for how we approach nutrition, wellness, and personal health management. Despite increasing health awareness, a significant gap remains in nutritional intake. Most individuals fail to meet their daily recommended vitamin and mineral requirements, a challenge that can lead to a cascade of health complications. According to a study from the National Institutes of Health, targeted vitamin supplementation plays a crucial role in enhancing immune function, boosting energy levels, and improving overall quality of life. The human body is a complex system that requires precise nutritional support. Water-soluble vitamins like the B-complex group, for instance, cannot be stored and must be consistently replenished. This reality underscores the importance of strategic, scientifically-backed nutritional supplementation. Deficiencies can manifest in various ways — from persistent fatigue and weakened immunity to more subtle impacts on metabolic function and cellular health. In response to these nutritional challenges, Kim Seokjin Lab has developed a groundbreaking solution that transcends traditional supplement approaches. The Immune Enhancer represents a sophisticated fusion of scientific innovation and practical design, specifically crafted for the demands of modern lifestyles. The product’s unique dual-format delivery — combining ready-to-drink vials with tablets — addresses the practical challenges of consistent nutritional intake. This innovative approach ensures that individuals can easily integrate high-quality nutrition into their busy lives, without compromising on effectiveness or convenience. What truly sets Immune Enhancer apart is its commitment to scientific excellence. This product offers a comprehensive blend of 19 essential vitamins and minerals, carefully formulated to optimize absorption and utilization in the body. Notably, it includes a high-concentration Vitamin B Complex (B1, B2, B6, B12), which plays a crucial role in enhancing immunity and boosting energy levels. Additionally, the ingredients are sourced from DSM, a global leader in nutritional science, ensuring the highest quality raw materials. Every component is designed for maximum bioavailability, ensuring that it is effectively absorbed and utilized by the body. Immune Enhancer goes beyond being just a supplement; with pharmaceutical-grade ingredients, it addresses the body’s fundamental nutritional needs, offering a holistic approach to health maintenance and improvement. The Korean health supplement market has emerged as a global leader in innovative, lifestyle-oriented nutritional solutions. This approach reflects a broader cultural understanding of health — not as a series of interventions, but as a continuous, proactive journey of well-being. Kim Seokjin Lab’s Immune Enhancer embodies this philosophy. It is more than a product; it’s a statement about how we should approach our health. By combining cutting-edge nutritional science with user-centric design, the supplement represents a new paradigm of preventative healthcare. The old adage “health is wealth” has never been more relevant. In an era of unprecedented medical knowledge and technological innovation, taking control of one’s health is the most strategic investment an individual can make. Immune Enhancer offers more than just vitamins — it provides a pathway to enhanced vitality. It represents a commitment to not just living longer, but living better. For those who understand that true wealth lies in sustained energy, robust immunity, and the ability to fully engage with life, this supplement is more than a choice — it’s a declaration of personal potential. With Kim Seokjin Lab’s Immune Enhancer, individuals can approach their health with precision, intention, and hope — transforming the very concept of what it means to truly thrive. Content written by Digital Journal sponsors.Apeiron launches as Web3 god game on app stores

OneDigital Investment Advisors LLC Reduces Holdings in Bruker Co. (NASDAQ:BRKR)

SHC directs Sindh government to submit details of cases against Dr Arif Alvi The Sindh High Court (SHC) on Thursday directed the Sindh government to submit the complete list of FIRs that have been lodged against former president and Pakistan Tehreek-e-Insaf (PTI) leader Dr Arif Alvi in the province of Sindh. The direction came on a petition filed by the former president seeking an injunction against arrest in blind FIRs. The petitioner’s counsel, Ali Tahir, submitted that the petitioner was falsely involved in the cases on the basis of political victimisation. He submitted that a number of FIRs had been lodged against the petitioner in the province, which he was unaware of and expressed apprehension that he might be arrested at any time in respect of such FIRs. He said the purpose of the FIRs was to harass the petitioner from continuing his peaceful political struggle against the government. He requested the high court to grant protection to the petitioner as there was apprehension that he could be arrested in blind FIRs. He asked for grant of an injunction against the registration of fresh cases against him. The SHC’s constitutional bench headed by Justice Mohammad Karim Khan Agha directed the provincial law officer and assistant prosecutor general to file complete list of FIRs registered against the petitioner in Sindh under the signature of the inspector general of police as well as the Federal Investigation Agency (FIA) director general on the next date of hearing. The high court also continued its interim restraining order with regard to arrest of the petitioner in any case till the next date of hearing and adjourned the hearing till December 19. Talking to journalists after the proceedings, Dr Alvi said that if former spy chief was being prosecuted for taking part in politics, it would also set an example for those officials who were at present taking part in politics. The SHC had earlier granted protective bail to the former president in three cases registered at different police stations of Punjab. Dr Alvi had moved the SHC for obtaining protective and transitory bail in connection with three criminal cases registered against him at Mianwali, Taxila and Rawalpindi police stations. The high court had also directed a provincial law officer to submit details of cases pending against another PTI leader Azam Khan Swati in the province with the signatures of the Sindh inspector general of police.

Previous: sports dance
Next: sports games